Related Experiment Videos
Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload
W C Darrah1, M D Sharpe, G M Guiraudon
1Department of Anaesthesia, London Health Sciences Centre, Ontario, Canada.
The Annals of Thoracic Surgery
|January 22, 1998
Summary
Intraaortic balloon counterpulsation improved cardiac function in a right heart failure model. This intervention enhanced left ventricular blood flow, suggesting left ventricular ischemia contributes to right ventricular dysfunction.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Critical Care Medicine
Background:
- Right ventricular (RV) dysfunction is a frequent complication post-heart transplantation.
- Myocardial ischemia is a suspected major factor contributing to RV dysfunction.
- This study investigated intraaortic balloon counterpulsation (IABP) in a model of acute RV pressure overload.
Purpose of the Study:
- To evaluate the efficacy of IABP in improving cardiac function during acute RV pressure overload.
- To explore the potential role of left ventricular ischemia in RV dysfunction.
Main Methods:
- RV failure was induced in 10 anesthetized sheep using a pulmonary artery constrictor.
- Hemodynamic parameters (blood pressure, RV systolic pressure, cardiac index, RV ejection fraction) were measured.
- Myocardial and organ perfusion were assessed using radioactive microspheres.
Main Results:
- Pulmonary artery constriction led to increased RV systolic pressure and decreased systemic blood pressure, RV ejection fraction, and cardiac index.
- Left ventricular blood flow significantly decreased post-constriction.
- IABP (1:1 assist) increased systemic blood pressure, cardiac index, RV ejection fraction, and left ventricular blood flow.
Conclusions:
- IABP significantly improved cardiac function in a model of RV failure.
- Augmented left coronary artery blood flow by IABP suggests left ventricular ischemia contributes to RV dysfunction via ventricular interdependence.
- Further investigation into IABP's safety and efficacy for acute right heart dysfunction is warranted.